First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
An article by a team of 12 Italian and 9 Russian scientists led by Francesco Vaia, Director of the Spallanzani Institute and Alexander Gintsburg, Director of the Gamaleya Center, has been published in medRxiv
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
In-house wet testing with live Omicron virus demonstrated that the Antigen test detects the Omicron variant with comparable sensitivity to other variants
The study will be published on the pre-print server, medRXiv, shortly
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
Subscribe To Our Newsletter & Stay Updated
